Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CTSK | P43235 | 17/20 | 0.43 |
| ▸ | CTSB | P07858 | 4/20 | 0.43 |
| ▸ | CTSS | P25774 | 3/20 | 0.43 |
| ▸ | DPP4 | P27487 | 1/20 | 0.36 |
| ▸ | CTSL | P07711 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.35 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.35 |
| ▸ | PKM | P14618 | 1/20 | 0.35 |
| ▸ | RAB9A | P51151 | 1/20 | 0.35 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24697974 | 1.00 | CTSK (0.43) | CTSKCTSBCTSSDPP4CTSL | |
| SCHEMBL24697991 | 0.83 | CTSK (0.32) | CTSKCTSBCTSS | |
| SCHEMBL26081106 | 0.75 | CTSC (0.47) | — | |
| SCHEMBL20172635 | 0.75 | CTSC (0.47) | — | |
| SCHEMBL6039833 | 0.72 | POLB (0.43) | ALDH1A1PKMKMT2ASMN1; SMN2 | |
| SCHEMBL6137246 | 0.69 | CTSK (0.57) | CTSKCTSBCTSSCTSLSMN1; SMN2 | |
| SCHEMBL22787764 | 0.68 | TSHR (0.47) | NPC1ALDH1A1PKMRAB9ASMN1; SMN2 | |
| SCHEMBL22787761 | 0.68 | TSHR (0.47) | NPC1ALDH1A1PKMRAB9ASMN1; SMN2 | |
| SCHEMBL10304355 | 0.68 | HPGD (0.40) | NPC1ALDH1A1RAB9AKMT2ASMN1; SMN2 | |
| SCHEMBL2155645 | 0.68 | CTSK (0.56) | CTSKCTSBCTSSCTSLSMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2022232573-A1 | CERTAIN N-(1-CYANO-2-PHENYLETHYL)-1,4-OXAZEPANE-2-CARBOXAMIDES FOR TREATING CYSTIC FIBROSIS | INSMED INCORPORATED (US) | 2022-11-03 | — | — | WO | disclosed |